Detalles de la búsqueda
1.
Structure-based discovery of cellular-active allosteric inhibitors of FAK.
Bioorg Med Chem Lett
; 23(6): 1779-85, 2013 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23414845
2.
Design, Synthesis, and Evaluation of the Highly Selective and Potent G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure.
J Med Chem
; 60(16): 6942-6990, 2017 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28699740
3.
Highly potent and orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activities of 1-benzazocine derivatives containing a sulfoxide moiety.
J Med Chem
; 49(6): 2037-48, 2006 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-16539392
4.
Discovery and characterization of novel allosteric FAK inhibitors.
Eur J Med Chem
; 61: 49-60, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22819505
5.
Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety.
Bioorg Med Chem
; 13(2): 363-86, 2005 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-15598559
6.
Synthesis of 1-benzothiepine and 1-benzazepine derivatives as orally active CCR5 antagonists.
Chem Pharm Bull (Tokyo)
; 52(2): 254-8, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14758013
7.
Orally active CCR5 antagonists as anti-HIV-1 agents 2: synthesis and biological activities of anilide derivatives containing a pyridine N-oxide moiety.
Chem Pharm Bull (Tokyo)
; 52(7): 818-29, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15256702
8.
Orally active CCR5 antagonists as anti-HIV-1 agents: synthesis and biological activity of 1-benzothiepine 1,1-dioxide and 1-benzazepine derivatives containing a tertiary amine moiety.
Chem Pharm Bull (Tokyo)
; 52(5): 577-90, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15133211
Resultados
1 -
8
de 8
1
Próxima >
>>